SynAct Pharma AB (SYNACT) NPV

Sell:21.55 SEKBuy:21.55 SEKPrice unchangedNo change

Prices delayed by at least 15 minutes
Sell:21.55 SEK
Buy:21.55 SEK
Change:Price unchangedNo change
Deal now
Prices delayed by at least 15 minutes
Sell:21.55 SEK
Buy:21.55 SEK
Change:Price unchangedNo change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

SynAct Pharma AB is a manufacturer of biological products. The Company is located in Lund, Sweden. It develops medicines for acute impairment in inflammatory diseases. The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

Key people

Anders Kronborg
Chairman of the Board
Jeppe Oevlesen
Chief Executive Officer, Director
Bjoern Westberg
Chief Financial Officer
Thomas Boesen
Chief Operating Officer
Thomas Jonassen
Chief Scientific Officer
Mads Bjerregaard
Chief Business Officer
Sten Scheibye
Director
Sten Sorensen
Director
Jeppe Ragnar Andersen
Independent Director
Click to see more

Key facts

  • Shares in issue
    53.33m
  • EPIC
    SYNACT
  • ISIN
    SE0008241491
  • Location
    Sweden
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    SEK 1.15bn
  • Employees
    8
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.